Venkatesan VM - Search Results

1

COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.

Khor LY, Bae K, Pollack A, Hammond ME, Grignon DJ, Venkatesan VM, Rosenthal SA, Ritter MA, Sandler HM, Hanks GE, Shipley WU, Dicker AP. Khor LY, et al. Among authors: venkatesan vm. Lancet Oncol. 2007 Oct;8(10):912-20. doi: 10.1016/S1470-2045(07)70280-2. Epub 2007 Sep 18. Lancet Oncol. 2007. PMID: 17881290 Free PMC article. Clinical Trial.

2

Prostate inhibin peptide (PIP) in prostate cancer: a comparative immunohistochemical study with prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP).

Garde SV, Sheth AR, Venkatesan VM, Panchal CJ, Porter AT, Grignon DJ. Garde SV, et al. Among authors: venkatesan vm. Cancer Lett. 1994 Apr 1;78(1-3):11-7. doi: 10.1016/0304-3835(94)90025-6. Cancer Lett. 1994. PMID: 7514089

3

Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?

Fisher BJ, Perera FE, Cooke AL, Opeitum A, Dar AR, Venkatesan VM, Stitt L, Radwan JS. Fisher BJ, et al. Among authors: venkatesan vm. Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):551-9. doi: 10.1016/s0360-3016(97)89483-7. Int J Radiat Oncol Biol Phys. 1997. PMID: 9231679

4

Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study.

Perera F, Engel J, Holliday R, Scott L, Girotti M, Girvan D, Chisela F, Venkatesan V. Perera F, et al. J Surg Oncol. 1997 Aug;65(4):263-7; discussion 267-8. doi: 10.1002/(sici)1096-9098(199708)65:4<263::aid-jso7>3.0.co;2-3. J Surg Oncol. 1997. PMID: 9274791 Review.

5

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM, Shipley WU; Radiation Therapy Oncology Group. Hanks GE, et al. J Clin Oncol. 2003 Nov 1;21(21):3972-8. doi: 10.1200/JCO.2003.11.023. J Clin Oncol. 2003. PMID: 14581419 Clinical Trial.

6

Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.

Pollack A, DeSilvio M, Khor LY, Li R, Al-Saleem TI, Hammond ME, Venkatesan V, Lawton CA, Roach M 3rd, Shipley WU, Hanks GE, Sandler HM. Pollack A, et al. J Clin Oncol. 2004 Jun 1;22(11):2133-40. doi: 10.1200/JCO.2004.09.150. J Clin Oncol. 2004. PMID: 15169799

7

Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.

Khor LY, Moughan J, Al-Saleem T, Hammond EH, Venkatesan V, Rosenthal SA, Ritter MA, Sandler HM, Hanks GE, Shipley WU, Pollack A. Khor LY, et al. Clin Cancer Res. 2007 Jun 15;13(12):3585-90. doi: 10.1158/1078-0432.CCR-06-2972. Clin Cancer Res. 2007. PMID: 17575222 Free PMC article. Clinical Trial.

8

Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202.

Che M, DeSilvio M, Pollack A, Grignon DJ, Venkatesan VM, Hanks GE, Sandler HM; RTOG. Che M, et al. Among authors: venkatesan vm. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1117-23. doi: 10.1016/j.ijrobp.2007.04.070. Epub 2007 Aug 8. Int J Radiat Oncol Biol Phys. 2007. PMID: 17689883 Free PMC article. Clinical Trial.

9

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer.

Horwitz EM, Bae K, Hanks GE, Porter A, Grignon DJ, Brereton HD, Venkatesan V, Lawton CA, Rosenthal SA, Sandler HM, Shipley WU. Horwitz EM, et al. J Clin Oncol. 2008 May 20;26(15):2497-504. doi: 10.1200/JCO.2007.14.9021. Epub 2008 Apr 14. J Clin Oncol. 2008. PMID: 18413638 Clinical Trial.

10

MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.

Khor LY, Bae K, Paulus R, Al-Saleem T, Hammond ME, Grignon DJ, Che M, Venkatesan V, Byhardt RW, Rotman M, Hanks GE, Sandler HM, Pollack A. Khor LY, et al. J Clin Oncol. 2009 Jul 1;27(19):3177-84. doi: 10.1200/JCO.2008.19.8267. Epub 2009 May 26. J Clin Oncol. 2009. PMID: 19470936 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters